Skip to content

Clinical trials

Phase 2 Hepatitis trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis Phase: Phase 2 Country / region: South Korea Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20151
20161
20171
20201
20213
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vir Biotechnology, Inc.2
Arbutus Biopharma Corporation1
AusperBio Therapeutics Inc.1
Brii Biosciences Limited1
F-star Therapeutics, Inc.1
Gilead Sciences1
GlaxoSmithKline1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis9
Hepatitis B7
Hepatitis B, Chronic6
Hepatitis, Chronic2
Liver Diseases2
Blood-Borne Infections1
Bronchiolitis Obliterans Syndrome1
Chronic Disease1
Communicable Diseases1
DNA Virus Infections1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.